Comparison of Biphozyl ® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation
Conditions: Critically Ill; Acute Kidney Injury; Renal Replacement Therapy; Continuous Renal Replacement Therapy; Continuous Veno-Venous Hemofiltration; Replacement Fluid; Phoxilium; Biphozyl; Anticoagulation; Regional Citrate Anticoagulation Interventions: Drug: CVVH with Phoxilium® in the first 48h after randomization; Drug: CVVH with Biphozyl® in the first 48h after randomization; Drug: CVVH with Phoxilium® in the second 48h after randomization (after previous 48h with Biphozyl®); Drug: CVVH with Biphozyl® in the second 48h after r andomization (after previous ...
Source: ClinicalTrials.gov - August 27, 2019 Category: Research Source Type: clinical trials
Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits
Condition: Dialysis Intervention: Diagnostic Test: Citrate dosage Sponsor: Dr David DE BELS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2019 Category: Research Source Type: clinical trials
